Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Prof Heidi Hudson appointed to international Committee on the Status of Women
2015-11-24

Prof Heidi Hudson is looking forward to advancing women scholars globally
Photo: Supplied

Prof Heidi Hudson, director of the Centre for Africa Studies at the University of the Free State, was recently appointed by the President of the International Studies Association (ISA) to serve on the Committee on the Status of Women from March 2016 to April 2018. 

Representing over 100 countries, ISA has more than 6 500 members in North America and internationally, and is the most respected and widely-known scholarly association in the field of International Studies. 

She anticipates that her role on the committee will complement her research interests in feminist security theory and practice in Africa. “I am looking forward to playing a part in the advancement of southern scholars, and the promotion of their voice in global academe.”   

Prior to Professor Hudson’s appointment, she served as a member of the executive of the Feminist Theory and Gender Studies (FTGS) Section of ISA.

Representing women of the world in academia

The Committee on the Status of Women has the task of reviewing the status of women in the profession, and making recommendations to the president and the Governing Council of ISA on ways of tracking and increasing the status and visibility of women in the profession.

“Some of the goals of the committee for the 2014 to 2016 period include reaching out to women scholars in the global south; creating an ISA networking website for women scholars; and surveying perceptions of the international relations climate and its needs,” said Prof Hudson. It is also responsible for “tracking gender balance within ISA and its journals, and supporting ISA regions in fulfilling the mission of the Committee on the Status of Women,” she added.

Connecting scholars globally since 1959

The ISA has been the premier organisation for connecting scholars and practitioners in fields of international studies, and promoting research and education. ISA cooperates with 57 international studies organisations in more than 30 countries, is a member of the International Social Science Council, and enjoys non-governmental consultative status at the United Nations.

Prof Hudson’s research interests concentrate on discursive and material gender deficits of liberal peacebuilding in the post colony, amongst other subjects. She is also co-editor of International Feminist Journal of Politics.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept